Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free EVOXW Stock Alerts

Evox Therapeutics (EVOXW) Competitors

Evox Therapeutics logo
$0.38 -0.03 (-6.67%)
As of 07/22/2026 02:56 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

EVOXW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy Evox Therapeutics stock or one of its competitors? MarketBeat compares Evox Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Evox Therapeutics include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does Evox Therapeutics compare to 60 Degrees Pharmaceuticals?

Evox Therapeutics (NASDAQ:EVOXW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment.

Company Net Margins Return on Equity Return on Assets
Evox TherapeuticsN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

In the previous week, Evox Therapeutics and Evox Therapeutics both had 1 articles in the media. Evox Therapeutics' average media sentiment score of 0.00 equaled 60 Degrees Pharmaceuticals'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evox Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
60 Degrees Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evox TherapeuticsN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats Evox Therapeutics on 1 of the 1 factors compared between the two stocks.

How does Evox Therapeutics compare to Alpha Tau Medical?

Evox Therapeutics (NASDAQ:EVOXW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

Company Net Margins Return on Equity Return on Assets
Evox TherapeuticsN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

In the previous week, Alpha Tau Medical had 2 more articles in the media than Evox Therapeutics. MarketBeat recorded 3 mentions for Alpha Tau Medical and 1 mentions for Evox Therapeutics. Alpha Tau Medical's average media sentiment score of 0.37 beat Evox Therapeutics' score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evox Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alpha Tau Medical
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evox TherapeuticsN/AN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Summary

Alpha Tau Medical beats Evox Therapeutics on 2 of the 2 factors compared between the two stocks.

How does Evox Therapeutics compare to Apollomics?

Apollomics (NASDAQ:APLMW) and Evox Therapeutics (NASDAQ:EVOXW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

In the previous week, Evox Therapeutics had 1 more articles in the media than Apollomics. MarketBeat recorded 1 mentions for Evox Therapeutics and 0 mentions for Apollomics. Apollomics' average media sentiment score of 0.00 equaled Evox Therapeutics'average media sentiment score.

Company Overall Sentiment
Apollomics Neutral
Evox Therapeutics Neutral

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Evox Therapeutics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
Evox TherapeuticsN/AN/AN/AN/AN/A

Summary

Apollomics and Evox Therapeutics tied by winning 1 of the 2 factors compared between the two stocks.

How does Evox Therapeutics compare to BioVie?

Evox Therapeutics (NASDAQ:EVOXW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

In the previous week, BioVie had 1 more articles in the media than Evox Therapeutics. MarketBeat recorded 2 mentions for BioVie and 1 mentions for Evox Therapeutics. BioVie's average media sentiment score of 0.37 beat Evox Therapeutics' score of 0.00 indicating that BioVie is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evox Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BioVie
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Net Margins Return on Equity Return on Assets
Evox TherapeuticsN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evox TherapeuticsN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

BioVie beats Evox Therapeutics on 2 of the 2 factors compared between the two stocks.

How does Evox Therapeutics compare to Cardio Diagnostics?

Evox Therapeutics (NASDAQ:EVOXW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

In the previous week, Evox Therapeutics had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 1 mentions for Evox Therapeutics and 0 mentions for Cardio Diagnostics. Evox Therapeutics' average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
Evox Therapeutics Neutral
Cardio Diagnostics Neutral

Company Net Margins Return on Equity Return on Assets
Evox TherapeuticsN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evox TherapeuticsN/AN/AN/AN/AN/A
Cardio Diagnostics$16.57KN/AN/AN/AN/A

Summary

Evox Therapeutics and Cardio Diagnostics tied by winning 1 of the 2 factors compared between the two stocks.

Get Evox Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVOXW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVOXW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EVOXW vs. The Competition

Export
MetricEvox TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$519.16M$7.01B$12.68B
Dividend YieldN/A3.90%2.67%9.42%
P/E RatioN/A3.1526.8323.95
Price / SalesN/A6,323.91576.15115.11
Price / CashN/A13.1350.6060.45
Price / BookN/A87.4810.566.16
Net IncomeN/A-$96.07M$3.60B$331.73M
7 Day PerformanceN/A-0.22%-1.35%-0.92%
1 Month Performance0.27%-0.58%-0.29%-2.23%
1 Year PerformanceN/A55.95%18.96%14.79%

Evox Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVOXW
Evox Therapeutics
N/A$0.38
-6.7%		N/AN/A$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.02
flat		N/A-61.5%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$3.66
flat		N/A+1,286.6%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
flat		N/A-41.5%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.55
-0.2%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:EVOXW) was last updated on 7/23/2026 by MarketBeat.com Staff.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel